Acknowledgement
Supported by : wonkwang university
References
-
Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-CD8-
${alpha}/{beta}$ T cells demonstrates preferential use of several V${beta}$ genes and an invariant TCR${alpha}$ chain. J Exp Med 1993;178:1-16. https://doi.org/10.1084/jem.178.1.1 -
Dellabona P, Padovan E, Casorati G, Brochkhaus M, Lanzavecchia A. An invariant V
${alpha}$ 24+V${beta}$ 11+ T cell receptor is expressed in all individuals by clonally expanded CD4- CD8- T cells. J Exp Med 1994;180:1171-80 https://doi.org/10.1084/jem.180.3.1171 - Spada FM, Koezuka Y, Steven A, Porcelli C. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998;188:1529-34 https://doi.org/10.1084/jem.188.8.1529
- Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, et al. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 2001;167:3114-22 https://doi.org/10.4049/jimmunol.167.6.3114
- Joyce S. CD1d and natural T cells : how their properties jump-start the immune system. Cell Mol Life Sci 2001;58: 442-69 https://doi.org/10.1007/PL00000869
-
Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, et al. Antitumor cytotoxicity mediated by ligand-activated human V
${\alpha}$ 24 NKT cells. Cancer Res 1999;59:5102-5 -
Denkers EY, Scharton-kerstein T, Barbieri S, Casper P, Sher A. A role for
$CD4^+$ $NK1.1^+$ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of$CD8^+$ function against intracellular infections. J Exp Med 1996;184:131-9 https://doi.org/10.1084/jem.184.1.131 -
Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, et al. Extreme Th1 bias of invariant
$V{\alpha}24J{\alpha}$ Q T cells in type 1 diabetes. Nature 1998;391:177-81 https://doi.org/10.1038/34419 - Seino KI, Fukao K, Muramoto K, Yanagisawa K, Takada Y, Kakuta S, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001;98:2577-81 https://doi.org/10.1073/pnas.041608298
-
Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, et al. Involvement of decidual V
${\alpha}$ 14 NKT cells in abortion. Proc Natl Acad Sci USA 2000;97:740-4 - Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high risk neuroblastoma with intensive chemoradiotherapy, autologus bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73 https://doi.org/10.1056/NEJM199910143411601
- Yang OO, Racke FK, Nguyen PT, Gausling R, Severino ME, Horton HF, et al. CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells : a feedback mechanism for immune regulation. J Immunol 2000;165:3756-62 https://doi.org/10.4049/jimmunol.165.7.3756
- Wilson SB, Byrne MC. Gene expression in NKT cells : defining a functionally distinct CD1d-restricted T cell subset. Curr Opin Immunol 2001;13:555-61 https://doi.org/10.1016/S0952-7915(00)00258-2
-
Ponzoni M, Casalaro A, Lanciotti M, Montaldo PG, Cornaglia- Ferraris P. The combination of
${\gamma}$ -interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neurblastoma cells. Cancer Res 1992;52:931-9 - Condorelli F, Sortino MA, Stella AMG, Canonico PL. Relative Contribution of different receptor subtype in the response of neuroblastoma cells to tumor necrosis factor-?. J Neurochem 2000;75:1172-9 https://doi.org/10.1046/j.1471-4159.2000.0751172.x
- Kawano T, Tanaka Y, Shimizu E, Kaneko Y, Kamata N, Sato H, et al. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int Immunol 1999; 11:881-7 https://doi.org/10.1093/intimm/11.6.881
- Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. Immunol Methods 1999;227:41-52 https://doi.org/10.1016/S0022-1759(99)00069-1
- Proffitt RT, Tran JV, Reynolds CP. A fluorescence digital image microscopy system for quantifying relative cell numbers in tissue culture plates. Cytometry 1996;24:204-13 https://doi.org/10.1002/(SICI)1097-0320(19960701)24:3<204::AID-CYTO3>3.0.CO;2-H
- Lecoeur H, Ledru E, Prevost MC, Gougeon ML. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric stainning methods. J Immunol Methods 1997;209:111-23 https://doi.org/10.1016/S0022-1759(97)00138-5
-
Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, et al. Human invariant natural killer cells activated by
${\alpha}$ -galactosylceramide have cytotoxic antitumor activity through mechanisms distinct from T cells and natural killer cells. Immunology 2000;99:229-34 https://doi.org/10.1046/j.1365-2567.2000.00952.x - Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nature Immunol 2000;1:515-20 https://doi.org/10.1038/82771
-
Kitamura H, Iwakabe K, Yahata T, Nishimura SI, Ohta A, Ohmi Y, et al. The natural killer T (NKT) cell ligand
${\alpha}$ - galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999;189:1121-7 https://doi.org/10.1084/jem.189.7.1121 - Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia 2003;17:1068-77 https://doi.org/10.1038/sj.leu.2402943
-
Takahashi T, Nieda M, Koezuka Y, Nicol A, Porcelli SA, Ishikawa Y, et al. Analysis of human V
${alpha}$ 24+ CD4+ NKT cells activated by${alpha}$ -glycosylceramide-pulsed monocytederived dendritic cells. J Immunol 2000;164:4458-64 https://doi.org/10.4049/jimmunol.164.9.4458 - Kayagaki N, Yagita H, Hirai H, Juji T. TRAIL expression by activated human CD4+V24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells. Blood 2001;97:2067-74 https://doi.org/10.1182/blood.V97.7.2067
-
Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, et al. In vitro anti-tumour activity of
${\alpha}$ - galactosylceramide-stimulated human invariant V${\alpha}24^+$ NKT cells against melanoma. Br J Cancer 2001;85:741-6 https://doi.org/10.1054/bjoc.2001.1973 - Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, et al. Cutting edge : Cross-talk between cells of the innate immune system : NKT cells rapidly activate NK cells. Immunol 1999;163:4647-50
- van der Vliet HJ, Nishi N, Koezuka Y, von Blomberg BM, van den Eertwegh AJ, Porcelli SA, et al. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Methods 2001;247:61-72 https://doi.org/10.1016/S0022-1759(00)00272-6
- Spada FM, Borriello F, Sugita M, Watts GF, Koezuka Y, Porcelli SA. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol 2000;30:3468-77 https://doi.org/10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C
- Kushner BH, Kramer K, Cheung NK. Phase II trial of the anti-G (D2) monoclonal antibody 3F8 and granulocytemacrophage colony-stimulating factor for neuroblastoma. J Clin Oncol 2001;19:4189-94 https://doi.org/10.1200/JCO.2001.19.22.4189
- Valteau-Couanet D, Leboulaire C, Maincent K, Tournier M, Hartmann O, Benard J, et al. Dendritic cells for NK/LAK activation : rationale for multicellular immunotherapy in neuroblastoma patients. Blood 2002;100:2554-61 https://doi.org/10.1182/blood.V100.7.2554
- Bernassola F, Scheuerpflug C, Herr I, Krammer PH, Debatin KM, Melino G. Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit. Cell Death Differ 1999;6:652-60 https://doi.org/10.1038/sj.cdd.4400537
- Lutz W, Fulda S, Jeremias I, Debatin KM, Schwab M. MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells. Oncogene 1998;17:339-46 https://doi.org/10.1038/sj.onc.1200201